The Hippo Signaling Pathway: an Emerging Anti-cancer Drug Target

被引:1
|
作者
Tao, Yuquan [1 ]
Cai, Feng [2 ]
Shan, Liang [1 ]
Jiang, Hongyuan [1 ]
Ma, Lifang [2 ]
Yu, Yongchun [1 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Shanghai Municipal Hosp Tradit Chinese Med, Shanghai 200071, Peoples R China
[2] Shanghai Univ Tradit Chinese Med, Shanghai Municipal Hosp Tradit Chinese Med, Dept Clin Lab Med, Shanghai 200071, Peoples R China
关键词
YES-ASSOCIATED PROTEIN; PROMOTES CELL-PROLIFERATION; AMPK-MEDIATED REGULATION; LIVER-CANCER CELLS; FORKHEAD BOX M1; BREAST-CANCER; TUMOR-SUPPRESSOR; LUNG-CANCER; YAP PATHWAY; GROWTH;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The Hippo signaling is a highly conserved pathway that plays important roles in tumorigenesis, stem cell self-renewal and differentiation, organ size control, and many other biological processes. Functions of the Hippo signaling pathway are regulated by complicated intracellular and extracellular signaling networks. When activated, the Hippo pathway functions as a tumor suppressor. However, dysregulation of this pathway contributes to increased cell proliferation and decreased apoptosis and differentiation. Therefore, regulation of Hippo signaling by pharmacological modulators may be a promising anticancer strategy. Here, we summarize potential anti-cancer drugs that target components of the Hippo pathway or regulate interactions between the Hippo signaling pathway and other signaling pathways.
引用
收藏
页码:7 / 18
页数:12
相关论文
共 50 条
  • [1] The Hippo signaling pathway provides novel anti-cancer drug targets
    Bae, June Sung
    Kim, Sun Mi
    Lee, Ho
    [J]. ONCOTARGET, 2017, 8 (09) : 16084 - 16098
  • [2] Targeting the Hippo Pathway for Anti-cancer Therapies
    Gong, Rui
    Yu, Fa-Xing
    [J]. CURRENT MEDICINAL CHEMISTRY, 2015, 22 (35) : 4104 - 4117
  • [3] TRANSLESION SYNTHESIS PATHWAY AS TARGET FOR ANTI-CANCER DRUG DESIGN
    Korzhnev, Dmitry
    [J]. PROTEIN SCIENCE, 2019, 28 : 42 - 42
  • [4] The Hippo pathway as a drug target in gastric cancer
    Qiao, Yiting
    Li, Tongyu
    Zheng, Shusen
    Wang, Hangxiang
    [J]. CANCER LETTERS, 2018, 420 : 14 - 25
  • [5] The Hippo Signaling Pathway in Drug Resistance in Cancer
    Zeng, Renya
    Dong, Jixin
    [J]. CANCERS, 2021, 13 (02) : 1 - 23
  • [6] Mitosis as an anti-cancer drug target
    Anna-Leena Salmela
    Marko J. Kallio
    [J]. Chromosoma, 2013, 122 : 431 - 449
  • [7] Mitosis as an anti-cancer drug target
    Salmela, Anna-Leena
    Kallio, Marko J.
    [J]. CHROMOSOMA, 2013, 122 (05) : 431 - 449
  • [8] Inhibition of Ras phenylation: A signaling target for novel anti-cancer drug design
    Lerner, EC
    Hamilton, AD
    Sebti, SM
    [J]. ANTI-CANCER DRUG DESIGN, 1997, 12 (04): : 229 - 238
  • [9] Advances of AKT pathway in human oncogenesis and as a target for anti-cancer drug discovery
    Cheng, George Z.
    Park, Sungman
    Shu, Shaokun
    He, Lili
    Kong, William
    Zhang, Weizhou
    Yuan, Zengqiang
    Wang, Lu-Hai
    Cheng, Jin Q.
    [J]. CURRENT CANCER DRUG TARGETS, 2008, 8 (01) : 2 - 6
  • [10] GPCRs: Emerging anti-cancer drug targets
    Gutierrez, Ainhoa Nieto
    McDonald, Patricia H.
    [J]. CELLULAR SIGNALLING, 2017, 41 : 65 - 74